<DOC>
	<DOC>NCT02133989</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of the ticlopidine + ginko biloba compared to clopidogrel in clopidogrel resistant patients undergoing carotid artery stent placement. The investigators hypothesized that ticlopidine + ginko biloba is superior than clopidogrel in terms of post-stent ischemic lesions in these patients without serious complications.</brief_summary>
	<brief_title>Clopidogrel Resistance and Embolism in Carotid Artery Stenting</brief_title>
	<detailed_description />
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Patients scheduled for stent implantation due to carotid stenosis Patients resistant to clopidogrel defined by platelet inhibition rate &lt;20% measured by Verify Now before carotid stenting Patients with informed consent Antiplatelet therapy other than aspirin, clopidogrel, or ticlopidine Unable to perform MRI scans Patients with hematologic abnormalities including neutrophil &lt;1500/ul, platelet &lt;100,000/uL, or AST/ALT &gt;120 U/L Unsuitable for participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Carotid stenosis</keyword>
	<keyword>Stenting</keyword>
	<keyword>Clopidogrel resistance</keyword>
	<keyword>Stroke, ischemic</keyword>
</DOC>